The efficiency of progesterone vaginal gel versus intramuscular progesterone for luteal phase supplementation in gonadotropin-releasing hormone antagonist cycles: A prospective clinical trial
Received 16 January 2009; received in revised form 29 September 2009; accepted 3 October 2009. published online 24 November 2009. Corrected Proof
We compared the efficiency of progesterone vaginal gel (PVG) with intramuscular progesterone (IMP) supplementation for luteal phase support after in vitro fertilization and embryo transfer in gonadotropin-releasing hormone (GnRH) antagonist cycles. The treatment outcomes were similar for PVG and IMP for luteal support in GnRH-antagonist protocols. With its ease of use, high tolerability by patients, and fewer side effects, PVG can be a successful alternative to IMP.
Istanbul Memorial Hospital IVF and Reproductive Genetics Unit, Istanbul, Turkey
Reprint requests: Semra Kahraman, M.D., Istanbul Memorial Hospital Piyale Pasa Bulvari Okmeydani-Sisli 34385, Istanbul, Turkey (FAX: +90 212 314 66 49).
S.K. has nothing to disclose. S.H.K. has nothing to disclose. G.K. has nothing to disclose.
ABSTRACT